Quality assurance in intracoronary brachytherapy. Recommendations for determining the planning target length to avoid geographic miss

Radiotherapy and Oncology

Volumn 71, Issue 3, 2004, Pages 311-318

  Schmid, Rainer ^a   Kirisits, Christian ^a   Syeda, Bonni ^a   Wexberg, Paul ^a   Siostrzonek, Peter ^a   Pokrajac, Boris ^a   Georg, Dietmar ^a   Glogar, Dietmar ^a   Poetter, Richard ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Geographic miss; Quality of treatment; Safety margin; Vascular brachytherapy

Indexed keywords

IRIDIUM 192; PHOSPHORUS 32; STRONTIUM 90;

ARTICLE; BLOOD VESSEL; BRACHYTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; DEVICE; DOSE CALCULATION; ENDOVASCULAR BRACHYTHERAPY; EVALUATION; HUMAN; MAJOR CLINICAL STUDY; NOMENCLATURE; PRIORITY JOURNAL; RESTENOSIS; RISK ASSESSMENT; TARGET ORGAN;

BRACHYTHERAPY; CORONARY STENOSIS; HUMANS; QUALITY ASSURANCE, HEALTH CARE; RADIATION DOSAGE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 2542495766     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2004.02.020     Document Type: Article

References (27)

1. Condado J.A., Waksman R., Gurdiel O., et al. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans. Circulation. 96:1997;727-732
2. Giap H.B., Bendre D.D., Huppe G.B., Teirstein P.S., Tripuraneni P. Source displacement during the cardiac cycle in coronary endovascular brachytherapy. Int J Radiat Oncol Biol Phys. 49:2001;273-277
3. Hong M.K., Park S.W., Moon D.H., et al. Impact of geographic miss on adjacent coronary artery segments in diffuse in-stent restenosis with beta-radiation therapy: angiographic and intravascular ultrasound analysis. Am Heart J. 143:2002;327-333
4. International Commission on Radiation Units and Measurements. Dose and volume specification for reporting interstitial therapy, ICRU Report 58. 1997;ICRU, Bethesda, MD
5. Kaluza G.L., Jenkins T.P., Mourtada F.A., et al. Targeting the adventitia with intracoronary beta-radiation: comparison of two dose prescriptions and the role of centering coronary arteries. Int J Radiat Oncol Biol Phys. 52:2002;184-191
6. Kim H.S., Waksman R., Cottin Y., et al. Edge stenosis and geographical miss following intracoronary gamma radiation therapy for in-stent restenosis. J Am Coll Cardiol. 37:2001;1026-1030
7. Kirisits C., Georg D., Wexberg P., Pokrajac B., Glogar D., Potter R. Determination and application of the reference isodose length (RIL) for commercial endovascular brachytherapy devices. Radiother Oncol. 64:2002;309-315
8. Kuntz R.E., Baim D.S. Prevention of coronary restenosis: the evolving evidence base for radiation therapy. Circulation. 101:2000;2130-2133
9. Lansky A.J., Dangas G., Mehran R., et al. Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiation. J Am Coll Cardiol. 39:2002;274-280
10. Lansky A.J., Popma J.J., Massullo V., et al. Quantitative angiographic analysis of stent restenosis in the scripps coronary radiation to inhibit intimal proliferation post stenting (SCRIPPS) trial. Am J Cardiol. 84:1999;410-414
11. Leon M.B., Teirstein P.S., Moses J.W., et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med. 344:2001;250-256
12. Nag S., Cole P.E., Crocker I., et al. The American Brachytherapy Society perspective on intravascular brachytherapy. Cardiovasc Radiat Med. 1:2001;8-19
13. Nath R., Amols H., Coffey C., et al. Intravascular brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group no 60. American Association of Physicists in Medicine. Med Phys. 26:1999;119-152
14. Parikh S., Nori D., Tripuraneni P. Geographic miss: a cause of treatment failure in radio-oncology applied to intracoronary radiation therapy. Circulation. 103:2001;E65-E66
15. 192Ir HDR brachytherapy for prophylaxis of restenosis after femoro-popliteal angioplasty: the prospective randomized Vienna-2 trial: radiotherapy parameters and risk factor analysis. Int J Radiat Oncol Biol Phys. 48:2000;923-931
16. Popma J.J., Suntharalingam M., Lansky A.J., et al. Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis. Circulation. 106:2002;1090-1096
17. Potter R., Van Limbergen E., Dries W., et al. Prescribing, recording, and reporting in endovascular brachytherapy. Quality assurance, equipment, personnel and education. Radiother Oncol. 59:2001;339-360
18. Quast U. Reporting vascular brachytherapy: proposal for a revision of the AAPM TG 60 report. American Association of Physicists in Medicine. Cardiovasc Radiat Med. 1:2001;378-381
19. Raizner A.E., Oesterle S.N., Waksman R., et al. Inhibition of restenosis with beta-emitting radiotherapy: report of the proliferation reduction with vascular energy trial (PREVENT). Circulation. 102:2000;951-958
20. Sabate M., Costa M.A., Kozuma K., et al. Geographic miss: a cause of treatment failure in radio-oncology applied to intracoronary radiation therapy. Circulation. 101:2000;2467-2471
21. Sianos G., Kay I.P., Costa M.A., et al. Geographical miss during catheter-based intracoronary beta-radiation: incidence and implications in the BRIE study. Beta-radiation in Europe. J Am Coll Cardiol. 38:2001;415-420
22. Syeda B., Siostrzonek P., Schmid R., et al. Geographical miss during intracoronary irradiation: impact on restenosis and determination of required safety margin length. J Am Coll Cardiol. 40:2002;1225-1231
23. Teirstein P.S., Massullo V., Jani S., et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med. 336:1997;1697-1703
24. Tripuraneni P., Parikh S., Giap H., et al. How long is enough? Defining the treatment length in endovascular brachytherapy. Catheter Cardiovasc Interv. 51:2000;147-153
25. Verin V., Popowski Y., de Bruyne B., et al. Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. N Engl J Med. 344:2001;243-249
26. Waksman R., Raizner A.E., Yeung A.C., Lansky A.J., Vandertie L. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet. 359:2002;551-557
27. Waksman R., White R.L., Chan R.C., et al. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation. 101:2000;2165-2171